NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









SafeHeal

SafeHeal

Private
ParisHealthcare & Life Scienceshttps://www.safeheal.com/

Last Round

Series C

Extension

Sep 10, 2025

Total Funding Raised

$115.86M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

SafeHeal is a medical device company that develops Colovac, an endoluminal bypass sheath designed to protect colorectal anastomosis and eliminate the need for diverting ostomies in patients undergoing colorectal surgery.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

medical devicecolorectal surgeryendoluminal bypassanastomosis protectionostomy alternativestoma preventionmedtechsurgical implantcolorectal resectionclinical trialsFDA approvalCE mark

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SafeHeal Comps

Public and private peers based on sector, stage, and business model.

SafeHeal comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

SafeHeal Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series C ExtensionSep 10, 2025
Series CApr 29, 2025
Series BJan 31, 2022
Series AMar 27, 2018

Key People

Founding team and executive leadership

Anne Osdoit

Board Director (formerly CEO)

Executive Team

SafeHeal Investors

Notable investors and investment history

SafeHeal investors
InvestorRounds
Asabys PartnersSeries C, Series C Extension
Gideon Strategic PartnersSeries C, Series C Extension
Sofinnova PartnersSeries C, Series B, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 7, 2026

    Grew 20% QoQ from 25 to 30 employees.

  • May 12, 2026

    Monthly visitors increased 31% MoM.

SafeHeal Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

SafeHeal Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about SafeHeal's valuation, stock price, and market status.

Firmographic Details

HeadquartersParis
Employee Range30
Year Founded2015
Last FundingSep 10, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.